TrialJournal of clinical pharmacology2020

Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam Versus Intravenous Midazolam and Placebo in Recreational Central Nervous System Depressant Users.

Frank Schippers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.